However, by using a Cox regression model of multivariate analysis, we found that only CRP/Alb remained as an independent prognostic marker for poor survival in patients with ovarian cancer along with residual disease, tumor stage and age, suggesting that CRP/Alb has a substantial impact on patient outcome. This evidence concerns the gene CRP and ovarian carcinoma.